Evidence map›Paper›PMID 26779544›Full record

ArticleResearch & reviews. Journal of pharmacy and pharmaceutical sciences

Particle Beam may have Higher Effectiveness in Treating Chemo-resistant Cancers than Low-LET Photon Beam Therapy.

Rupak Pathak, Martin Hauer-Jensen

Registry-linked trialAbstract read
PubMed Full text at PMC
In one paragraph

Article in Research & reviews. Journal of pharmacy and pharmaceutical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07706335 (Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07706335 not yet recruitingnot on this map

Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.

TypeobservationalSponsorAssiut UniversityRan2026 to 2029Enrolled100ConditionsSTEMI, No-Reflow Phenomenon, Diabetic PatientArmsPCI
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rupak PathakDivision of Radiation Health, Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Martin Hauer-JensenDivision of Radiation Health, Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Surgical Service, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA.

Funding

The Role o f Tetrahydrobiopterin (BH4) Bioavailability in Radiation-induced Skin InjuryP20GM109005 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI WOLFE, TATIANA · 2015 to 2024
$21.1M
Molecular Pathogenesis of Radiation EnteropathyR37CA071382 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI HAUER-JENSEN, MARTIN · 2008 to 2013
$1.7M
NCI NIH HHS R37 CA071382NIGMS NIH HHS P20 GM109005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CancerDNA repairMethotrexateParticle beamRadiotherapy

Identifiers

PMID26779544
PMCPMC4712956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.